Removal of intrahepatic bile duct stone could reduce the risk of cholangiocarcinoma

World J Clin Cases. 2024 Apr 16;12(11):1881-1884. doi: 10.12998/wjcc.v12.i11.1881.

Abstract

Hepatolithiasis (HL) poses a significant risk for cholangiocarcinoma (CCA) development, with reported incidences ranging from 5%-13%. Risk factors include older age, smoking, hepatitis B infection, and prolonged HL duration. Chronic inflammation and mechanical stress on the biliary epithelium contribute to CCA pathogenesis. Hepatectomy reduces CCA risk by removing stones and atrophic liver segments. However, residual stones and incomplete removal increase CCA risk. Kim et al identified carbohydrate antigen 19-9, carcinoembryonic antigen, and stone laterality as CCA risk factors, reaffirming the importance of complete stone removal. Nonetheless, challenges remain in preventing CCA recurrence post-surgery. Longer-term studies are needed to elucidate CCA risk factors further.

Keywords: Biliary stone; Cholangiocarcinoma; Cholangitis; Common bile duct stone; Hepatolithiasis.

Publication types

  • Editorial